Consultation with a physician is advised in case of: Painful abdominal symptoms of undetermined cause before the treatment is started; Insufficient therapeutic effect after several days.
Lactulose should be administered with care to patients who are intolerant to lactose (see Excipients/Inactive Ingredients under Description).
With regard to sugar content, the dose normally used to treat constipation should not pose a problem for diabetics. However, the dose used to treat HE is usually much higher and may cause problem in diabetic patients. Sugar content of the medicine should be taken into consideration for diabetics.
Chronic use of unadjusted doses and misuse can lead to diarrhea and disturbance of the electrolyte balance.
This product contains lactose, galactose and small amounts of fructose. Therefore, patients with the rare hereditary problems of galactose or fructose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.
When administration as a retention enema, due to the strong cathartic effect, fecal incontinence, bedsoiling, and peri-anal irritation due to the acidic stool can be expected.
The hydration status of the patient should be observed carefully.
Should not be given when any abdominal symptoms present.
Effects on ability to drive and use machine: Based on its pharmacological properties, lactulose is likely to have no or negligible influence on the ability to drive and use machines.
Use in Children: Use of laxatives in children should be exceptional and under medical supervision.
It should be taken into account that the defaecation reflex could be disturbed during the treatment.